Literature DB >> 6600227

Association of primary sclerosing cholangitis with HLA-B8.

R W Chapman, Z Varghese, R Gaul, G Patel, N Kokinon, S Sherlock.   

Abstract

The frequency of HLA antigens was studied in 25 patients with primary sclerosing cholangitis and compared with a control group of 562 kidney donors. Fourteen patients also had ulcerative colitis. A significant increase in the frequency of HLA-B8 (60%) was found in the primary sclerosing cholangitis patients compared with controls (25%) (p less than 0.001). HLA-B8 was found in eight patients with ulcerative colitis. The frequency of HLA-B12 was significantly decreased (8%) compared with controls (30%) (p less than 0.02). Piecemeal necrosis was observed on liver histology in 66% of HLA-B8 positive and 50% of HLA-B8 negative patients. Low titres of serum autoantibodies were frequently found in the primary sclerosing cholangitis group but did not correspond to the presence of HLA-B8. Raised serum concentrations of IgM and IgG were not related to HLA-B8. This study has shown that in patients with primary sclerosing cholangitis there exists a disease susceptibility gene closely associated with the B locus of the major histocompatibility complex which may be modified by other factors such as ulcerative colitis. Patients with ulcerative colitis and HLA-B8 may be particularly liable to develop primary sclerosing cholangitis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600227      PMCID: PMC1419910          DOI: 10.1136/gut.24.1.38

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

Review 1.  HLA and liver disease.

Authors:  A L Eddleston; R Williams
Journal:  Br Med Bull       Date:  1978-09       Impact factor: 4.291

Review 2.  [Primary fibrosing cholangitis (author's transl)].

Authors:  E Roseau
Journal:  Nouv Presse Med       Date:  1978 Aug 26-Sep 2

3.  Histocompatibility antigens in patients with inflammatory-bowel disease.

Authors:  P Asquith; P Mackintosh; P L Stokes; G K Holmes; W T Cooke
Journal:  Lancet       Date:  1974-01-26       Impact factor: 79.321

4.  Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors:  A L Eddleston; R Williams
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

5.  Primary or secondary sicca complex? Investigation in primary biliary cirrhosis by histocompatibility testing.

Authors:  A N Hamlyn; D Adams; S Sherlock
Journal:  Br Med J       Date:  1980-08-09

6.  Sclerosing cholangitis and primary biliary cirrhosis--a disease spectrum?

Authors:  H J Fee; H Gewirtz; J Schiller; W P Longmire
Journal:  Ann Surg       Date:  1977-11       Impact factor: 12.969

7.  HLA in different forms of chronic active hepatitis. A comparison between adult patients and children.

Authors:  J Freudenberg; H Baumann; W Arnold; J Berger; K H Büschenfelde
Journal:  Digestion       Date:  1977       Impact factor: 3.216

8.  Enhanced antibody responses in active chronic hepatitis: relation to HLA-B8 and HLA-B12 and porto-systemic shunting.

Authors:  R M Galbraith; A L Eddleston; R Williams; A D Webster; J Pattison; D Doniach; L A Kennedy; J R Batchelor
Journal:  Lancet       Date:  1976-05-01       Impact factor: 79.321

9.  HLA-B8, immunoglobulins, and antibody responses in alcohol-related liver disease.

Authors:  M Y Morgan; M G Ross; C M Ng; D M Adams; H C Thomas; S Sherlock
Journal:  J Clin Pathol       Date:  1980-05       Impact factor: 3.411

10.  HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies.

Authors:  I R Mackay; B D Tait
Journal:  Gastroenterology       Date:  1980-07       Impact factor: 22.682

View more
  58 in total

Review 1.  Primary sclerosing cholangitis.

Authors:  S A Mitchell; R W Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Autoimmune hepatitis and its variant syndromes.

Authors:  Z Ben-Ari; A J Czaja
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

3.  HLA antigens in primary sclerosing cholangitis.

Authors:  K Noguchi; M Kobayashi; A Yagihashi; Y Yoshida; K Terasawa; A Konno; F Ichida; M Venek; S Iwatsuki; T E Starzl
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

Review 4.  Association of primary sclerosing cholangitis and celiac disease: a case report and review of the literature.

Authors:  Abdullah M S Al-Osaimi; Carl L Berg
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

Review 5.  Are the inflammatory bowel diseases autoimmune disorders?

Authors:  J Snook
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

6.  Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations.

Authors:  Christopher L Bowlus; Chin-Shang Li; Tom H Karlsen; Benedicte A Lie; Carlo Selmi
Journal:  Liver Transpl       Date:  2010-11       Impact factor: 5.799

Review 7.  Primary sclerosing cholangitis: updates in diagnosis and therapy.

Authors:  Piero Portincasa; Michele Vacca; Antonio Moschetta; Michele Petruzzelli; Giuseppe Palasciano; Karel J van Erpecum; Gerard P van Berge-Henegouwen
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

Review 8.  Immunopathogenesis of primary sclerosing cholangitis.

Authors:  Joy Worthington; Sue Cullen; Roger Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

9.  Ulcerative colitis and sarcoidosis.

Authors:  G D Barr; D J Shale; D P Jewell
Journal:  Postgrad Med J       Date:  1986-05       Impact factor: 2.401

Review 10.  The genetics of complex cholestatic disorders.

Authors:  Gideon M Hirschfield; Roger W Chapman; Tom H Karlsen; Frank Lammert; Konstantinos N Lazaridis; Andrew L Mason
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.